158 related articles for article (PubMed ID: 32737697)
1. ASO Author Reflection: Axillary Dissection for Negative Lymph Nodes in Inflammatory Breast Cancer-Need for Clinical Trials to Reassess Standard of Care.
Postlewait LM; Lucci A
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):676-677. PubMed ID: 32737697
[No Abstract] [Full Text] [Related]
2. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
3. The need for lymph node dissection in nonmetastatic breast cancer.
Pesce C; Morrow M
Annu Rev Med; 2013; 64():119-29. PubMed ID: 23020881
[TBL] [Abstract][Full Text] [Related]
4. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
5. ASO Author Reflections: Avoiding an Axillary Lymph Node Dissection: The Benefit of Neoadjuvant Chemotherapy for Occult Primary Breast Cancer.
Botty van den Bruele A; Plitas G; Pilewskie M
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):865-866. PubMed ID: 32725524
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: Male Breast Cancer and Axillary Lymph Node Dissection: Time to Rethink the Algorithm?
Chung SH; Cassidy MR
Ann Surg Oncol; 2023 Sep; 30(9):5619-5620. PubMed ID: 37191857
[No Abstract] [Full Text] [Related]
7. Observational study of axilla treatment for breast cancer patients with 1-3 positive micrometastases or macrometastases in sentinel lymph nodes.
Oba MS; Imoto S; Toh U; Wada N; Kawada M; Kitada M; Masuda N; Taguchi T; Minami S; Jinno H; Sakamoto J; Morita S;
Jpn J Clin Oncol; 2014 Sep; 44(9):876-9. PubMed ID: 25030214
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
[TBL] [Abstract][Full Text] [Related]
9. [Sentinel lymph node status and axillary lymph node dissection in the surgical treatment of breast cancer].
Cserni G
Orv Hetil; 2014 Feb; 155(6):203-15. PubMed ID: 24486844
[TBL] [Abstract][Full Text] [Related]
10. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
[TBL] [Abstract][Full Text] [Related]
11. Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer.
Gatek J; Petru V; Kosac P; Ratajsky M; Duben J; Dudesek B; Jancik P; Zabojnikova M; Katrusak J; Opelova P; Podrazska L; Vazan P; Kudlova P; Holik P; Melichar B; Vrana D
Neoplasma; 2020 Nov; 67(6):1329-1334. PubMed ID: 32749847
[TBL] [Abstract][Full Text] [Related]
12. [SENTINEL LYMPH NODE BIOPSY AND AXILLARY DISSECTION].
Takahashi M
Nihon Geka Gakkai Zasshi; 2016 Nov; 117(6):509-15. PubMed ID: 30173475
[TBL] [Abstract][Full Text] [Related]
13. Targeted axillary dissection and sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy - a retrospective study.
Coufal O; Zapletal O; Gabrielová L; Fabian P; Schneiderová M
Rozhl Chir; 2018; 97(12):551-557. PubMed ID: 30646734
[TBL] [Abstract][Full Text] [Related]
14. Sentinel node biopsy to avoid axillary lymph node dissection in breast cancer.
Motomura K; Komoike Y; Nagumo S; Kasugai T; Hasegawa Y; Inaji H; Noguchi S; Koyama H
Breast Cancer; 2002; 9(4):337-43. PubMed ID: 12459716
[TBL] [Abstract][Full Text] [Related]
15. [Sentinel node biopsy and axillary clearence in early breast cancer--An algorithm with explanations and queries].
Cserni G
Magy Seb; 2016 Mar; 69(1):4-13. PubMed ID: 26901689
[TBL] [Abstract][Full Text] [Related]
16. ASO Author Reflections: Completion Axillary Dissection Can Be Avoided but Inconsistent Trial Design Complicates Choosing Between Alternative Strategies.
Castelo M; Scheer AS
Ann Surg Oncol; 2020 Aug; 27(8):2677-2678. PubMed ID: 32206953
[No Abstract] [Full Text] [Related]
17. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J
BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412
[TBL] [Abstract][Full Text] [Related]
18. Is there a need for axillary dissection in breast cancer?
Wilson JP; Mattson D; Edge SB
J Natl Compr Canc Netw; 2011 Feb; 9(2):225-30. PubMed ID: 21310843
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Axillary US in Early-Stage Breast Cancer: Potential to Prevent Unnecessary Axillary Lymph Node Dissection.
Kim GR; Choi JS; Han BK; Lee JE; Nam SJ; Ko EY; Ko ES; Lee SK
Radiology; 2018 Jul; 288(1):55-63. PubMed ID: 29558291
[TBL] [Abstract][Full Text] [Related]
20. Preceding sentinel node biopsy in early breast cancer: does it affect the number of axillary lymph nodes?
Braems G; Denys H; Cocquyt V; Van den Broecke R
Acta Chir Belg; 2008; 108(6):691-5. PubMed ID: 19241919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
